Allergen-Specific Immunotherapy

Allergen-Specific Immunotherapy

December 13, 2016 at 8:21 AM 0 comments

*Esther Helen Steveling-Klein Department of Dermatology and Allergology, University Hospital Basel, Basel, Switzerland *Correspondence to esthersteveling@gmail.com Disclosure: Esther Helen Steveling-Klein received travel support from ALK-Abello. Received: 17.05.16 Accepted: 08.08.16 Citation: EMJ. 2016;1[4]:78-87. Abstract Allergen-specific immunotherapy remains the only causal treatment of allergic disease to date. Its efficacy in symptom reductionRead More

Management of Cardiovascular Risk Factors in Type 2 Diabetes Mellitus Patients

Management of Cardiovascular Risk Factors in Type 2 Diabetes Mellitus Patients

December 13, 2016 at 8:20 AM 0 comments

Iciar Martín-Timón, Cristina Sevillano-Collantes, Juan José Marín-Peñalver, *Francisco Javier del Cañizo-Gómez Endocrinology Department, University Hospital Infanta Leonor, School of Medicine, Complutense University, Madrid, Spain *Correspondence to fjcanizog@salud.madrid.org Disclosure: The authors have declared no conflicts of interest. Received: 07.06.16 Accepted: 29.09.16 Citation: EMJ. 2016;1[4]:89-97. Abstract People with Type 2 diabetes mellitusRead More

Role of Coagulation Factor Concentrates in the Operating Room

Role of Coagulation Factor Concentrates in the Operating Room

December 13, 2016 at 8:19 AM 0 comments

*Cheng-Hock Toh,1,2 Yasir Alhamdi1 1. Institute of Infection and Global Health, University of Liverpool, Liverpool, UK 2. Roald Dahl Haemostasis and Thrombosis Centre, Royal Liverpool University Hospital, Liverpool, UK *Correspondence to Toh@liverpool.ac.uk Disclosure: The authors have declared no conflicts of interest. Received: 24.05.16 Accepted: 19.08.16 Citation: EMJ. 2016;1[4]:98-105. Abstract TheRead More

Gene Delivery from Stents for Prevention of In-Stent Restenosis

Gene Delivery from Stents for Prevention of In-Stent Restenosis

December 13, 2016 at 8:18 AM 0 comments

*Ilia Fishbein,1,2 Ivan S. Alferiev,1,2 Michael Chorny,1,2 Robert J. Levy1,2 1. The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA 2. University of Pennsylvania, Philadelphia, Pennsylvania, USA *Correspondence to fishbein@email.chop.edu Disclosure: The authors have declared no conflicts of interest. Received: 20.04.16 Accepted: 24.08.16 Citation: EMJ. 2016;1[4]:106-113. Abstract The increasing sophistication ofRead More

Revolution of Drug-Eluting Coronary Stents: An Analysis of Market Leaders

Revolution of Drug-Eluting Coronary Stents: An Analysis of Market Leaders

December 13, 2016 at 8:17 AM 0 comments

*Ashok S. Thakkar,1 Bhargav A. Dave2,3 1. Clinical Research, Meril Life Sciences Pvt., Ltd, Vapi, India 2. Manish Therapy Services, Madison Heights, Texas, USA 3. Department of Physical Therapy, Srinivas University, Mangaluru, Karnataka, India *Correspondence to drashokthakkar@gmail.com Disclosure: Ashok S. Thakkar is an employee of Meril Life Science Pvt., Ltd.Read More

Ethical Issues on Awake Thoracic Surgery for Seriously Chronically Ill Patients

Ethical Issues on Awake Thoracic Surgery for Seriously Chronically Ill Patients

August 23, 2016 at 8:29 AM 0 comments

*Gabor Kiss Consultant in Anaesthesiology and Surgical Intensive Care, Department of Cardiothoracic and Vascular Surgery, University Hospital Félix Guyon, Saint Denis (La Réunion), France *Correspondence to gaborkiss2001@hotmail.com Disclosure: The author has declared no conflicts of interest. Received: 31.03.16 Accepted: 12.07.16 Citation: EMJ. 2016;1[3]:12-14.

Endoscopic Management of Sessile Serrated Polyps of the Colon

Endoscopic Management of Sessile Serrated Polyps of the Colon

August 23, 2016 at 8:28 AM 0 comments

Karen Ma, *Joshua Melson Division of Digestive Diseases, Rush University Medical Center, Chicago, Illinois, USA *Correspondence to Joshua_Melson@rush.edu Disclosure: The authors have declared no conflicts of interest. Received: 04.04.16 Accepted: 13.07.16 Citation: EMJ. 2016;1[3]:16-20.

Regorafenib in Advanced and Refractory Gastrointestinal Cancers

Regorafenib in Advanced and Refractory Gastrointestinal Cancers

August 23, 2016 at 8:27 AM 0 comments

Summary of Presentations from the European Society of Medical Oncology (ESMO) 18th World Congress on Gastrointestinal Cancer (WCGI) held in Barcelona, Spain from 28th June–2nd July 2016 Speakers: Eric Van Cutsem,1 Michael Ducreux,2 Diether Lambrechts3 1. University Hospitals Leuven, Leuven, Belgium 2. Gustave Roussy Cancer Campus Grand Paris, Villejuif, FranceRead More

Optimising Cancer Immunotherapy: Challenges and Opportunities

Optimising Cancer Immunotherapy: Challenges and Opportunities

August 23, 2016 at 8:26 AM 0 comments

Summary of Presentations from a prIME Oncology Scientific Exchange on 21st May 2016 in Amsterdam, Netherlands Authors: Tristin Abair,1 Robert E. Coleman2 Co-Chairs: Alexander M. M. Eggermont,3 Ignacio Melero4 Speakers: Joachim G. Aerts,5 Mario Colombo,6 George Coukos,7 Eric Deutsch,3 Thomas Powles8 Panel Members: Jürgen Becker,9 Christian Blank,10 Rolf Kiessling,11 MicheleRead More

Challenges and Considerations in the Management of Hyperkalaemia in Patients With Chronic Kidney Disease

Challenges and Considerations in the Management of Hyperkalaemia in Patients With Chronic Kidney Disease

August 23, 2016 at 8:25 AM 0 comments

This CME symposium took place on 23rd May 2016 as a part of the European Renal Association – European Dialysis and Transplantation Association (ERA-EDTA) Congress 2016 in Vienna, Austria Chairperson: David Goldsmith1 Speakers: Johannes F. E. Mann,2,3 Martin H. de Borst3 1. Renal Unit, Guy’s and St Thomas’ Hospital, London,Read More